Idiopathic pulmonary fibrosis trials in Canada

In Canada 12 Also abroad 111

12 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Ajax, Montreal, Québec, Toronto, Trois-Rivières, Vancouver, Windsor
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Ajax, Montreal, Trois-Rivières, Vancouver
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 3Not yet taking people in Canada
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Burlington, Greenfield Park, Hamilton, Montreal, Owen Sound, Sherwood Park, Toronto, Trois-Rivières, Vancouver
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Ajax, Burlington, Kingston, North York, Saint-Charles-Borromée, Sherbrooke, Sherwood Park, Vancouver
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Taking people
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Where
Ajax, Windsor
Age
40 years and over
People
1,100 worldwide
Run by
PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Ajax, Hamilton, Québec, Toronto, Trois-Rivières, Vancouver
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 2Taking people
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Where
Ajax, Calgary, Halifax, Montreal, Sherbrooke, St. John's, Toronto, Trois-Rivières, Vancouver
Age
40 years and over
People
160 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT07194382 · EU 2025-523431-19-00
Phase 2Taking people
Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
Where
Windsor
Age
40 years to 80 years
People
153
Run by
Mannkind Corporation
See details and how to joinNCT07679893
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Trois-Rivières
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
No phaseTaking people
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Where
Vancouver
Age
18 years to 80 years
People
500 worldwide
Run by
University of Massachusetts, Worcester
See details and how to joinNCT06855329
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Ajax, Hamilton, Montreal, Québec, Saskatoon, Sherbrooke, Vancouver
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00
No phaseTaking people
Skeletal Muscle Function in Interstitial Lung Disease
Where
Vancouver
Age
40 years to 80 years
People
40
Run by
University of British Columbia
See details and how to joinNCT03800017